This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hernandez, Y. J.
Right arrow Articles by Flotte, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hernandez, Y. J.
Right arrow Articles by Flotte, T. R.

 Previous Article  |  Next Article 

Journal of Virology, October 1999, p. 8549-8558, Vol. 73, No. 10
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Latent Adeno-Associated Virus Infection Elicits Humoral but Not Cell-Mediated Immune Responses in a Nonhuman Primate Model

Yosbani J. Hernandez,1,2,3 Jianming Wang,1,2,3 William G. Kearns,4 Scott Loiler,1,2,3 Amy Poirier,1,2,3 and Terence R. Flotte1,2,3,*

Gene Therapy Center1 and Departments of Pediatrics2 and Molecular Genetics and Microbiology,3 University of Florida College of Medicine, Gainesville, Florida 32610, and Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 212874

Received 6 April 1999/Accepted 18 June 1999

Latent infection with wild-type (wt) adeno-associated virus (AAV) was studied in rhesus macaques, a species that is a natural host for AAV and that has some homology to humans with respect to the preferred locus for wt AAV integration. Each of eight animals was infected with an inoculum of 1010 IU of wt AAV, administered by either the intranasal, intramuscular, or intravenous route. Two additional animals were infected intranasally with wt AAV and a helper adenovirus (Ad), while one additional animal was inoculated with saline intranasally as a control. There were no detectable clinical or histopathologic responses to wt AAV administration. Molecular analyses, including Southern blot, PCR, and fluorescence in situ hybridization, were performed 21 days after infection. These studies indicated that AAV DNA sequences persisted at the sites of administration, albeit at low copy number, and in peripheral blood mononuclear cells. Site-specific integration into the AAVS1-like locus was observed in a subset of animals. All animals, except those infected by the intranasal route with wt AAV alone, developed a humoral immune response to wt AAV capsid proteins, as evidenced by a >= fourfold rise in anti-AAV neutralizing titers. However, only animals infected with both wt AAV and Ad developed cell-mediated immune responses to AAV capsid proteins. These findings provide some insights into the nature of anti-AAV immune responses that may be useful in interpreting results of future AAV-based gene transfer studies.

* Corresponding author. Mailing address: University of Florida Gene Therapy Center, Academic Research Bldg. Rm. R1-191, 1600 SW Archer Rd. (JHMHSC Box 100266), Gainesville, FL 32610-0266. Phone: (352) 846-2739. Fax: (352) 846-2738. E-mail: flotttr{at}peds.ufl.edu.

Journal of Virology, October 1999, p. 8549-8558, Vol. 73, No. 10
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Madsen, D., Cantwell, E. R., O'Brien, T., Johnson, P. A., Mahon, B. P. (2009). Adeno-associated virus serotype 2 induces cell-mediated immune responses directed against multiple epitopes of the capsid protein VP1. J. Gen. Virol. 90: 2622-2633 [Abstract] [Full Text]  
  • Brantly, M. L., Chulay, J. D., Wang, L., Mueller, C., Humphries, M., Spencer, L. T., Rouhani, F., Conlon, T. J., Calcedo, R., Betts, M. R., Spencer, C., Byrne, B. J., Wilson, J. M., Flotte, T. R. (2009). Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy. Proc. Natl. Acad. Sci. USA 106: 16363-16368 [Abstract] [Full Text]  
  • Schnepp, B. C., Jensen, R. L., Clark, K. R., Johnson, P. R. (2009). Infectious Molecular Clones of Adeno-Associated Virus Isolated Directly from Human Tissues. J. Virol. 83: 1456-1464 [Abstract] [Full Text]  
  • Stone, D., Liu, Y., Li, Z.-Y., Strauss, R., Finn, E. E., Allen, J. M., Chamberlain, J. S., Lieber, A. (2008). Biodistribution and Safety Profile of Recombinant Adeno-Associated Virus Serotype 6 Vectors following Intravenous Delivery. J. Virol. 82: 7711-7715 [Abstract] [Full Text]  
  • Zaiss, A. K., Cotter, M. J., White, L. R., Clark, S. A., Wong, N. C. W., Holers, V. M., Bartlett, J. S., Muruve, D. A. (2008). Complement Is an Essential Component of the Immune Response to Adeno-Associated Virus Vectors. J. Virol. 82: 2727-2740 [Abstract] [Full Text]  
  • Du, L., Zhao, G., Lin, Y., Sui, H., Chan, C., Ma, S., He, Y., Jiang, S., Wu, C., Yuen, K.-Y., Jin, D.-Y., Zhou, Y., Zheng, B.-J. (2008). Intranasal Vaccination of Recombinant Adeno-Associated Virus Encoding Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Spike Protein Induces Strong Mucosal Immune Responses and Provides Long-Term Protection against SARS-CoV Infection. J. Immunol. 180: 948-956 [Abstract] [Full Text]  
  • Schnepp, B. C., Jensen, R. L., Chen, C.-L., Johnson, P. R., Clark, K. R. (2005). Characterization of Adeno-Associated Virus Genomes Isolated from Human Tissues. J. Virol. 79: 14793-14803 [Abstract] [Full Text]  
  • Geoffroy, M.-C., Epstein, A. L., Toublanc, E., Moullier, P., Salvetti, A. (2004). Herpes Simplex Virus Type 1 ICP0 Protein Mediates Activation of Adeno-Associated Virus Type 2 rep Gene Expression from a Latent Integrated Form. J. Virol. 78: 10977-10986 [Abstract] [Full Text]  
  • Peden, C. S., Burger, C., Muzyczka, N., Mandel, R. J. (2004). Circulating Anti-Wild-Type Adeno-Associated Virus Type 2 (AAV2) Antibodies Inhibit Recombinant AAV2 (rAAV2)-Mediated, but Not rAAV5-Mediated, Gene Transfer in the Brain. J. Virol. 78: 6344-6359 [Abstract] [Full Text]  
  • Palmer, G. A., Brogdon, J. L., Constant, S. L., Tattersall, P. (2004). A Nonproliferating Parvovirus Vaccine Vector Elicits Sustained, Protective Humoral Immunity following a Single Intravenous or Intranasal Inoculation. J. Virol. 78: 1101-1108 [Abstract] [Full Text]  
  • Gao, G., Alvira, M. R., Somanathan, S., Lu, Y., Vandenberghe, L. H., Rux, J. J., Calcedo, R., Sanmiguel, J., Abbas, Z., Wilson, J. M. (2003). Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc. Natl. Acad. Sci. USA 100: 6081-6086 [Abstract] [Full Text]  
  • Schnepp, B. C., Clark, K. R., Klemanski, D. L., Pacak, C. A., Johnson, P. R. (2003). Genetic Fate of Recombinant Adeno-Associated Virus Vector Genomes in Muscle. J. Virol. 77: 3495-3504 [Abstract] [Full Text]  
  • Nathwani, A. C., Davidoff, A. M., Hanawa, H., Hu, Y., Hoffer, F. A., Nikanorov, A., Slaughter, C., Ng, C. Y. C., Zhou, J., Lozier, J. N., Mandrell, T. D., Vanin, E. F., Nienhuis, A. W. (2002). Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood 100: 1662-1669 [Abstract] [Full Text]  
  • KAMINSKI, J. M., HUBER, M. R., SUMMERS, J. B., WARD, M. B. (2002). Design of a nonviral vector for site-selective, efficient integration into the human genome. FASEB J. 16: 1242-1247 [Abstract] [Full Text]  
  • Mastakov, M. Y., Baer, K., Symes, C. W., Leichtlein, C. B., Kotin, R. M., During, M. J. (2002). Immunological Aspects of Recombinant Adeno-Associated Virus Delivery to the Mammalian Brain. J. Virol. 76: 8446-8454 [Abstract] [Full Text]  
  • Flotte, T. R., Humbert, M., Fadel, E., Raffestin, B., Darmon, M., Capron, F., Simonneau, G., Dartevelle, P., Hamon, M., Adnot, S. (2002). Recombinant Adeno-Associated Virus Gene Therapy for Cystic Fibrosis and {alpha}1-Antitrypsin Deficiency. Chest 121 : 98S-102S [Abstract] [Full Text]  
  • Chao, H., Walsh, C. E. (2001). Induction of tolerance to human factor VIII in mice. Blood 97: 3311-3312 [Abstract] [Full Text]  
  • Flotte, T., Agarwal, A., Wang, J., Song, S., Fenjves, E. S., Inverardi, L., Chesnut, K., Afione, S., Loiler, S., Wasserfall, C., Kapturczak, M., Ellis, T., Nick, H., Atkinson, M. (2001). Efficient Ex Vivo Transduction of Pancreatic Islet Cells With Recombinant Adeno-Associated Virus Vectors. Diabetes 50: 515-520 [Abstract] [Full Text]  
  • Angella, G. J., Sherwood, M. B., Balasubramanian, L., Doyle, J. W., Smith, M. F., van Setten, G., Goldstein, M., Schultz, G. S. (2000). Enhanced Short-Term Plasmid Transfection of Filtration Surgery Tissues. IOVS 41: 4158-4162 [Abstract] [Full Text]  
  • LaVail, M. M., Yasumura, D., Matthes, M. T., Drenser, K. A., Flannery, J. G., Lewin, A. S., Hauswirth, W. W. (2000). Ribozyme rescue of photoreceptor cells in P23H transgenic rats: Long-term survival and late-stage therapy. Proc. Natl. Acad. Sci. USA 10.1073/pnas.210319397v1 [Abstract] [Full Text]  
  • Seo, B. B., Wang, J., Flotte, T. R., Yagi, T., Matsuno-Yagi, A. (2000). Use of the NADH-Quinone Oxidoreductase (NDI1) Gene of Saccharomyces cerevisiae as a Possible Cure for Complex I Defects in Human Cells. J. Biol. Chem. 275: 37774-37778 [Abstract] [Full Text]  
  • LaVail, M. M., Yasumura, D., Matthes, M. T., Drenser, K. A., Flannery, J. G., Lewin, A. S., Hauswirth, W. W. (2000). Ribozyme rescue of photoreceptor cells in P23H transgenic rats: Long-term survival and late-stage therapy. Proc. Natl. Acad. Sci. USA 97: 11488-11493 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»